Ruxolitinib Treatment and Risk of B‐cell Lymphomas in Myeloproliferative Neoplasms
American Journal of Hematology - United States
doi 10.1002/ajh.25489
Full Text
Open PDFAbstract
Available in full text
Categories
Date
May 1, 2019
Authors
Publisher
Wiley